Testosterone 45802-0281-39
- Manufacturer
- Padagis Israel Pharmaceuticals Ltd
- Dosage Form
- Gel
- Route
- Topical
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CIII
- Marketing Start
- June 27, 2019
- Listing Expires
- December 31, 2026
- Application
- ANDA205781
Active Ingredients
| Ingredient | Strength |
|---|---|
| Testosterone | 20.25 mg/1.25g |
Drug Class
Androgen [EPC]Androgen Receptor Agonists [MoA]Androgen [EPC]
Selected Package
45802-0281-39Selected30 PACKET in 1 CARTON (45802-281-39) / 1.25 g in 1 PACKET (45802-281-03)